Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.0 and removed Revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-18T19:56:34.000Z thumbnail image
  4. Check
    54 days ago
    Change Detected
    Summary
    A new page revision label 'Revision: v3.4.2' is added, and an operating-status notice about government funding as well as the older 'Revision: v3.4.1' label are removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:32:51.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Added a system-wide notice about government funding status and NIH operations. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T04:14:07.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added: Show glossary, the metadata field 'Last Update Submitted that Met QC Criteria', and the revision note 'Revision: v3.4.0'. Removed/modified: the existing label 'Last Update Submitted that met QC Criteria' (case change), 'No FEAR Act data' (case change), and the old revision note 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T01:51:47.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, or contact information observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:39:36.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T22:50:35.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.